Wordt geladen...
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Stroke is a major cause of death and long-term disability in industrialized countries, and the only causal therapy for stroke comprises recombinant tissue plasminogen activator(rt-PA)-mediated recanalization of the occluded vessel. New experimental strategies focus on neuroregenerative approaches, a...
Bewaard in:
Hoofdauteurs: | , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Dove Medical Press
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3781740/ https://ncbi.nlm.nih.gov/pubmed/24198521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/SCCAA.S7820 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|